MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0056
0.00 (0.00%)
At close: Jun 1, 2026

MediXall Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
May '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
107811489151
Market Cap Growth
37.97%-100.00%-31.76%28.06%-41.36%1.29%
Enterprise Value
238011489152
Last Close Price
0.010.000.641.050.922.00

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
May '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
3.8601309.127582.56-56393.83
PB Ratio
-0.320-21.14-334.29232.49380.68
P/TBV Ratio
-----3712.03

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
May '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
5.769.121346.417581.73-56425.09

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
May '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.17-0.59-0.77-0.930.560.30
Net Debt / Equity Ratio
-0.16-0.59-0.77-0.74-1.13-0.83
Net Debt / EBITDA Ratio
-0.30-0.98-0.45-0.040.070.10
Net Debt / FCF Ratio
-0.48-3.11-0.79-0.050.110.14
Asset Turnover
0.900.580.060.01-0.00
Quick Ratio
0.010.000.000.050.580.90
Current Ratio
0.010.000.000.281.010.90
Return on Equity (ROE)
----29680.60%-1521.69%-727.30%
Return on Assets (ROA)
-363.77%-460.46%-396.33%-286.77%-287.25%-256.57%
Return on Capital Employed (ROCE)
55.00%60.00%181.60%6790.80%-1135.90%-770.40%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
May '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-206.82%-3510312.31%-8.80%-5.45%-6.68%-2.26%
FCF Yield
-102.29%-945804.61%-4.59%-4.12%-4.66%-1.55%
Buyback Yield / Dilution
-13.83%-9.00%-11.96%-14.98%-22.25%-14.03%